Web-based intervention for managing cancer pain in Asian American breast cancer survivors
Official title: Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors
Run by Vanderbilt University · NCT06085313 · Data updated 2026-11-12
This study is testing a new online program to help Asian American breast cancer survivors manage their pain and depression better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Vanderbilt University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | February 20, 2024 |
| Main results expected | August 31, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT06085313 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older who identify as Chinese, Korean, or Japanese, have a history of breast cancer, and are experiencing cancer pain and depressive symptoms.
✕Probably not a fit
Patients who are under 18 years old or those diagnosed with breast cancer within the past five years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance a web-based program called CAPA, designed for cancer pain management, specifically tailored for Asian American breast cancer survivors. The program will be further developed to include components addressing depressive symptoms, which are often overlooked in pain management. The study will involve two phases: the first phase focuses on expert review and usability testing of the new components, while the second phase will evaluate the efficacy of the optimized intervention in improving pain experiences. The goal is to provide a culturally sensitive approach to pain management that considers the unique needs of this population.
Why it matters
Potential benefit: If successful, this intervention could significantly improve pain management and overall quality of life for Asian American breast cancer survivors experiencing pain and depressive symptoms.
How similar studies have gone: Other studies have shown success with culturally tailored interventions for pain management, indicating potential for this approach to be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * women aged 18 years and older who identify as Chinese, Korean, or Japanese; * have had a breast cancer diagnosis in the past; * can read and write English, Mandarin (simplified or traditional), Korean, or Japanese; * have access to the internet through computers or mobile devices (mobile phones and tablets); * have experienced cancer pain during the past week (at least 1 on a scale from 0 to 5 \[no symptom=0, mild symptom that does not bother=1, somewhat bothering symptom=2, moderate symptom=3, severe symptom=4, and worst possible symptom=5\]); * have experienced depressive symptoms during the past two weeks (1 to 10 on the Patient Health Questionnaire) which is equivalent to the cut-point of minimal to moderate depression. Exclusion Criteria: * less than 18 years old because their cancer experience would be different from that of adults. * Those who are in treatment or not in treatment, but who were diagnosed with breast cancer within the past five years, will be excluded. * Those who participated in the PI's pilot studies will be excluded. * The participants of R33 phase will exclude those in active depression treatment regardless of their level of depression. * Those without Internet access will be excluded, but those with Internet access through community/group computers will be included.
Where it's running
-
Vanderbilt University
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Eun Ok Im, PhD, MPH — Vanderbilt University
- Study coordinator: Wonshik Chee, PhD
- Email: cai.help@vanderbilt.edu
- Phone: 615-343-8439
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Navigation help for breast cancer patients with social needs
This study tests a patient navigator program to connect breast cancer patients with unmet social needs to community resources.
-
Morning Activation to Boost Mood After Stroke
A six-week behavioral program is tested to see if it helps mood and daily functioning in adults who had a stroke and feel depressed or slow to get going in the morning.
-
Sleep More, Stress Less with Neuralli Mood
This 90-day, open-label study tests whether daily Neuralli Mood capsules can help adults feel less stressed, sleep better, and improve mood and burnout symptoms.
-
Blended Baduanjin and Green Tea Program for Depressive Symptoms in Older Adults
This study tests whether a 12-week combo of gentle Baduanjin exercise and green tea consumption can help reduce depressive symptoms and improve gut health and quality of life in Hong Kong’s community-dwelling adults aged 65–84.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.